Ghost mitochondria drive metastasis through adaptive GCN2/Akt therapeutic vulnerability [Cell Biology]
Cancer metabolism, including in mitochondria, is a disease hallmark and therapeutic target, but its regulation is poorly understood. Here, we show that many human tumors have heterogeneous and often reduced levels of Mic60, or Mitofilin, an essential scaffold of mitochondrial structure. Despite a catastrophic collapse of mitochondrial integrity, loss of...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Jagadish C. Ghosh, Michela Perego, Ekta Agarwal, Irene Bertolini, Yuan Wang, Aaron R. Goldman, Hsin-Yao Tang, Andrew V. Kossenkov, Catherine J. Libby, Lucia R. Languino, Edward F. Plow, Annamaria Morotti, Luisa Ottobrini, Marco Locatelli, David W. Speiche Tags: Cell Biology Biological Sciences Source Type: research
More News: Academies | Biology | Cancer | Cancer & Oncology | Cytology | Mitochondria | Mitochondrial Disease | Science